Ultragenyx Pharmaceutical, Inc. (RARE)
22.51
-0.21
(-0.92%)
USD |
NASDAQ |
Feb 23, 16:00
22.54
+0.03
(+0.13%)
After-Hours: 19:59
Ultragenyx Pharmaceutical Total Assets (Quarterly) : 1.532B for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 823.61M |
| Johnson & Johnson | 199.21B |
| CorMedix, Inc. | 750.86M |
| Insmed, Inc. | 2.265B |
| Regeneron Pharmaceuticals, Inc. | 40.56B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.605B |
| Shareholders Equity (Quarterly) | -80.00M |
| Debt to Equity Ratio | -15.65 |
| Current Ratio | 2.477 |
| Net Debt Paydown Yield | -3.06% |